Name: Moderna Inc. (NASDAQ:MRNA) | Balance Sheet: Assets (Quarterly)
Creator: Stock Analysis on Net

Balance Sheet: Assets
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

Moderna Inc., consolidated balance sheet: assets (quarterly data)

US$ in millions

	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cash and cash equivalents	1,644)	2,478)	2,051)	2,907)	2,932)	3,801)	3,441)	3,205)	3,027)	2,873)	5,048)	6,848)	5,550)	5,603)	5,442)	2,624)	1,506)	1,762)	392)	236)	174)	152)	503)
Investments	5,223)	6,010)	6,472)	5,697)	4,641)	4,658)	5,482)	6,697)	5,321)	5,024)	5,067)	3,879)	3,356)	2,387)	2,293)	1,984)	1,771)	955)	826)	867)	885)	919)	606)
Accounts receivable, net	1,564)	163)	137)	892)	1,866)	232)	1,113)	1,385)	2,695)	2,691)	3,173)	3,175)	3,142)	2,020)	3,210)	1,391)	191)	33)	7)	5)	8)	5)	7)
Inventory	412)	399)	295)	202)	487)	715)	732)	949)	2,077)	1,921)	1,942)	1,441)	965)	643)	494)	47)	—)	—)	—)	—)	—)	—)	—)
Prepaid expenses and other current assets	823)	611)	645)	627)	873)	1,193)	1,354)	1,195)	1,177)	1,054)	1,120)	728)	412)	316)	264)	253)	110)	46)	25)	20)	28)	23)	25)
Current assets	9,666)	9,661)	9,600)	10,325)	10,799)	10,599)	12,122)	13,431)	14,297)	13,563)	16,350)	16,071)	13,425)	10,969)	11,703)	6,298)	3,577)	2,797)	1,250)	1,129)	1,094)	1,097)	1,141)
Investments, non-current	2,335)	2,326)	3,638)	4,677)	5,273)	6,105)	7,442)	8,318)	8,655)	10,162)	9,171)	6,843)	6,442)	4,207)	468)	639)	692)	355)	502)	160)	280)	365)	438)
Property, plant and equipment, net	2,381)	2,196)	2,063)	1,945)	1,952)	2,280)	2,018)	2,018)	2,019)	1,324)	1,341)	1,241)	845)	794)	372)	297)	277)	230)	202)	201)	204)	209)	213)
Right-of-use assets, operating leases	784)	775)	697)	713)	765)	130)	117)	121)	113)	122)	132)	142)	115)	104)	89)	90)	92)	92)	101)	86)	—)	—)	—)
Deferred tax assets	81)	81)	81)	81)	—)	1,480)	1,262)	982)	920)	785)	521)	326)	81)	66)	50)	—)	—)	—)	—)	—)	—)	—)	—)
Other non-current assets	556)	641)	650)	685)	661)	1,290)	1,164)	988)	52)	87)	94)	46)	15)	13)	12)	13)	13)	12)	13)	13)	13)	14)	14)
Non-current assets	6,137)	6,019)	7,129)	8,101)	8,651)	11,285)	12,003)	12,427)	11,759)	12,480)	11,259)	8,598)	7,498)	5,184)	991)	1,039)	1,074)	689)	818)	461)	496)	588)	665)
Total assets	15,803)	15,680)	16,729)	18,426)	19,450)	21,884)	24,125)	25,858)	26,056)	26,043)	27,609)	24,669)	20,923)	16,153)	12,694)	7,337)	4,651)	3,486)	2,068)	1,589)	1,591)	1,685)	1,806)

Total assets experienced a period of rapid expansion between 2020 and early 2022, growing from approximately 2 billion USD to a peak of 27.6 billion USD in March 2022. Following this peak, a gradual contraction is observed, with total assets declining to 15.8 billion USD by September 2024. This trajectory suggests a massive capitalization phase followed by a period of asset normalization or strategic reallocation.

Liquidity and Cash Management: Cash and cash equivalents saw an exponential increase during 2020 and 2021, peaking at 6.8 billion USD in December 2021. Since that peak, there has been a consistent downward trend, with the balance falling to 1.6 billion USD by September 2024. Complementing this, current investments fluctuated but generally remained high, peaking at 6.7 billion USD in December 2022 before moderating to 5.2 billion USD in late 2024. The shift from cash to investments and the subsequent overall decline in liquid assets indicate significant capital expenditure or operational spending.
Working Capital Dynamics: Accounts receivable exhibited extreme volatility, surging to a peak of 3.2 billion USD in March 2021 before experiencing a sharp decline. By mid-2023, receivables dropped as low as 232 million USD, although a recent increase to 1.5 billion USD in September 2024 indicates a shift in revenue collection cycles. Inventory levels, which were non-existent in the 2019 data, emerged in late 2020 and peaked at 2.1 billion USD in September 2022. Inventory has since contracted to 412 million USD, reflecting a reduction in stockpiled goods.
Long-Term Asset Investment: Property, plant, and equipment (PP&E) demonstrate a steady and consistent upward trend, rising from approximately 200 million USD in 2019 to 2.4 billion USD by September 2024. This suggests a sustained commitment to building physical infrastructure and manufacturing capacity. In contrast, non-current investments peaked aggressively at 10.2 billion USD in June 2022 and have since declined sharply to 2.3 billion USD, suggesting the liquidation of long-term financial holdings to fund other activities.
Other Non-Current Assets: Deferred tax assets showed growth through early 2023, peaking at 1.5 billion USD in June 2023 before dropping significantly to 81 million USD. Right-of-use assets remained relatively stable until a notable increase in September 2023, rising to 765 million USD and remaining at that elevated level through September 2024, indicating new long-term lease commitments.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Moderna Inc. (NASDAQ:MRNA)

Balance Sheet: AssetsQuarterly Data

Assets: Selected Items

Current Assets: Selected Items

Balance Sheet: Assets
Quarterly Data